Merit Medical Systems | MMSI - Gross Profit On Sales


Merit Medical Systems reported $195.35M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
3M USD 2.06B 667M Dec/2025
Abbott USD 6.54B 625M Dec/2025
AngioDynamics USD 44.78M 2.93M Sep/2025
Anika Therapeutics USD 19.18M 3.6M Dec/2025
AtriCure USD 105.34M 4M Dec/2025
Baxter International USD 577M 373M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Boston Scientific USD 3.68B 136M Dec/2025
Cooper Companies USD 695.2M 44.4M Dec/2025
Dexcom USD 792.7M 61.3M Dec/2025
Edwards Lifesciences USD 1.23B 18.7M Dec/2025
Globus Medical USD 535.95M 49.28M Dec/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
ICU Medical USD 202.98M 2.1M Dec/2025
Insulet USD 568.6M 58.5M Dec/2025
Integra LifeSciences USD 217.1M 10.11M Dec/2025
J&J USD 16.6B 118M Dec/2025
Medtronic USD 5.41B 27M Dec/2025
Merit Medical Systems USD 195.35M 8.94M Dec/2025
Olympus JPY 164.9B 3.6B Dec/2025
Pfizer USD 3.54B 7.61B Sep/2025
STAAR Surgical USD 43.74M 34.13M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Surmodics USD -11.54M 3.99M Sep/2024
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.45M 144.2M Dec/2025
Terumo JPY 153.19B 6.2B Dec/2025
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025